Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-21

Clinical Trial Update: Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study [Phase 3]

View source ↗

Summary

Retrospective Phase 3 study assessing growth hormone supplementation on blastocyst euploid rate in advanced maternal age patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Growth Hormone (somatropin)

Snippet

Sponsor: ShangHai Ji Ai Genetics & IVF Institute | Conditions: Growth Hormone, Advanced Maternal Age | Phase 3 | Status: COMPLETED